ZF2001, trade-named ZIFIVAX or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute of Microbiology at the Chinese Academy of Sciences. This vaccine candidate is in Phase III trials with participants in China, Ecuador, Malaysia, Pakistan, and Uzbekistan.

Anhui Zhifei Longcom ZF2001, trade-named ZIFIVAX or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute of Microbiology at the Chinese Academy of Sciences. This vaccine candidate is in Phase III trials with participants in China, Ecuador, Malaysia, Pakistan, and Uzbekistan.

Which organization has developed ZF2001 COVID-19 vaccine?

Q. Which organization has developed ZF2001 COVID-19 vaccine?
Answer: Anhui Zhifei Longcom
Notes:

ZF2001, trade-named ZIFIVAX or ZF-UZ-VAC-2001, is an adjuvanted protein subunit COVID-19 vaccine developed by Anhui Zhifei Longcom in collaboration with the Institute of Microbiology at the Chinese Academy of Sciences.
This vaccine candidate is in Phase III trials with participants in China, Ecuador, Malaysia, Pakistan, and Uzbekistan.

Current Affairs Section

Daily MCQs

Monthly MCQs

Topic Wise CA MCQs

Current Affairs Articles

CA MCQs in Other Languages

GK MCQs Section

SSC/RRB/States Level MCQs

PDF Ebooks Store

UPSC Exams

UPSC Prelims Exams

UPSC Mains Questions & Answers

Banking Exams